| Pharmaceutical active ingredients: |
| Dextran |
| Available forms, composition and doses of Polyglucinum: |
| N / A |
| Polyglucinum medical category: |
| Human:Replacement preparations |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B05AA05 - Dextran |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Polycycline | Tetracycline | Unidentified Pharmaceutical Company |
| Polydesis | Polyvinyl Alcohol | Unidentified Pharmaceutical Company |
| Polyethylene Glycol Ointment | Macrogol 3350; Macrogol 400 | Unidentified Pharmaceutical Company |
| Polyflon | Polytetrafluoroethylene | Unidentified Pharmaceutical Company |
| Poly-Giron | Thalidomide | Unidentified Pharmaceutical Company |
| Polyglusol | Dextran | Unidentified Pharmaceutical Company |
| Polyglycine | Glycine | Unidentified Pharmaceutical Company |
| Polygon | Sodium Tripolyphosphate | Unidentified Pharmaceutical Company |
| Polygorskite Fibers | Attapulgite | Unidentified Pharmaceutical Company |
| Polygripan | Thalidomide | Unidentified Pharmaceutical Company |